CompletedPhase 3

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

United States2,105 participantsStarted 2004-12

Plain-language summary

The purpose of this study is to assess the safety of gabapentin, as compared to placebo, in a potential over-the-counter population with reports of occasional sleeplessness

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects \>/= 12 years of age who reported occasional sleeplessness in month prior to screening Exclusion Criteria: * Females who were pregnant or breastfeeding

What they're measuring

Adverse Events

Timeframe: Day 45

Trial details

NCT IDNCT00666575

SponsorPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Transient Insomnia trials